These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34397871)
1. Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation. Wang X; Meng Q; Wang Y; Gao Y Medicine (Baltimore); 2021 Aug; 100(32):e26545. PubMed ID: 34397871 [TBL] [Abstract][Full Text] [Related]
2. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer. Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349 [TBL] [Abstract][Full Text] [Related]
3. MMP14 predicts a poor prognosis in patients with colorectal cancer. Cui G; Cai F; Ding Z; Gao L Hum Pathol; 2019 Jan; 83():36-42. PubMed ID: 30120968 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer. Dong Y; Chen G; Gao M; Tian X Gene; 2015 May; 563(1):29-34. PubMed ID: 25748728 [TBL] [Abstract][Full Text] [Related]
5. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1. Kasurinen A; Gramolelli S; Hagström J; Laitinen A; Kokkola A; Miki Y; Lehti K; Yashiro M; Ojala PM; Böckelman C; Haglund C Cancer Med; 2019 Nov; 8(16):6995-7005. PubMed ID: 31560170 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of cyclin-dependent kinase 7 and matrix metalloproteinase-14 expression contribute to metastatic properties of gastric cancer. Naseh G; Mohammadifard M; Mohammadifard M IUBMB Life; 2016 Oct; 68(10):799-805. PubMed ID: 27562173 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail. Zuo QF; Cao LY; Yu T; Gong L; Wang LN; Zhao YL; Xiao B; Zou QM Cell Death Dis; 2015 Nov; 6(11):e2000. PubMed ID: 26610210 [TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma. Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357 [TBL] [Abstract][Full Text] [Related]
9. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis. Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis. Li Y; Su Z; Wei B; Qin M; Liang Z Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516 [TBL] [Abstract][Full Text] [Related]
11. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis. Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer. Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis. Jia Z; Gao J; Wang Y; Zhou T; Zhang X; Zu G Sci Rep; 2022 Oct; 12(1):16786. PubMed ID: 36202905 [TBL] [Abstract][Full Text] [Related]
14. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis. Hu L; Luo H; Wang W; Li H; He T PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707 [TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
16. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC. Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis. Cheng F; Zeng C; Zeng L; Chen Y Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic analyses of HDACs in human gastric cancer based on bioinformatic analysis. Chen L; Fei Y; Zhao Y; Chen Q; Chen P; Pan L Medicine (Baltimore); 2021 Jul; 100(27):e26554. PubMed ID: 34232196 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression of E-cadherin correlates with poor prognosis and unfavorable clinicopathological features in gastric carcinoma: a meta-analysis. Lu G; Cai Z; Jiang R; Tong F; Tu J; Chen Y; Fu Y; Sun J; Zhang T Aging (Albany NY); 2024 Jun; 16(12):10271-10298. PubMed ID: 38870263 [TBL] [Abstract][Full Text] [Related]
20. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma. Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]